RecruitingNot ApplicableNCT05700799

HEalth Advocate for Liver Transplant - Pilot


Sponsor

University of California, San Francisco

Enrollment

10 participants

Start Date

Mar 20, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The Health Advocate for Liver Transplant (HEAL-Tx) Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for pediatric liver transplant patients and measure acceptability and feasibility according to RE-AIM.


Eligibility

Max Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This pilot study tests whether a health advocate program — using a trained peer or professional to support families navigating post-transplant care — can improve outcomes and reduce disparities for children who have received a liver transplant. **You may be eligible if...** - Your child (under 18) has received a liver transplant - You (as parent or guardian) are willing to participate and can be contacted for follow-up - You speak English or Spanish - You live in the United States **You may NOT be eligible if...** - The caregiver is unwilling or unable to complete the study surveys - The child is a ward of the state (e.g., in foster care) - You do not speak English or Spanish - Your child is 18 or older at enrollment Talk to your doctor to see if this trial is right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interventions

BEHAVIORALHealth Advocate

The Health Advocate intervention will include helping pediatric liver transplant recipients and their families address unmet household social needs (e.g., food insecurity), improve patient-provider communication, and enhance care coordination.


Locations(1)

University of California San Francisco

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05700799


Related Trials